CYCLOPHOSPHAMIDE 500 mg/25mL (Cyclophosphamide INJECTION, POWDER, FOR SOLUTION) 500 mg/25mL

Cyclophosphamide 500 mg/25mL is a powder for solution used in various medical treatments. This versatile medication is available in single-dose vials for intravenous or oral administration.

Strength

500 mg/25mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (10019-938-01) / 25 mL in 1 VIAL, SINGLE-DOSE (10019-938-25)

Manufacturer / TM Owner

Baxter Healthcare Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cyclophosphamide is commonly used in the management of certain cancers and autoimmune conditions. It works by interfering with the growth of cancer cells or suppressing the immune system. The specific uses of cyclophosphamide can vary, and it is often prescribed based on individual patient needs.

Side Effects

Cyclophosphamide may cause side effects such as nausea, vomiting, and hair loss. Some individuals might experience fatigue or changes in blood cell counts. It is important to discuss potential effects with a healthcare provider.

Precautions & Warnings

Cyclophosphamide should be handled with care, as it can be harmful if not used correctly. It is essential to follow the instructions provided by a healthcare professional. Proper storage and disposal are crucial to ensure safety.

Avoid Interactions

Cyclophosphamide may interact with other medications, including those that affect the immune system or blood cell production. It is important to inform healthcare providers about all medications being taken to avoid potential interactions.

Frequently Asked Questions

Cyclophosphamide is used in the treatment of certain cancers and autoimmune conditions. It works by interfering with cell growth or suppressing the immune system.

Cyclophosphamide can be administered intravenously or orally, depending on the specific treatment plan.

Common side effects may include nausea, vomiting, hair loss, and fatigue. It is important to discuss potential effects with a healthcare provider.

Yes, cyclophosphamide may interact with other medications, particularly those affecting the immune system or blood cell production.

Cyclophosphamide should be stored according to the instructions provided by the manufacturer to ensure its effectiveness and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.